#NICE #NHS #Generics #Biosimilars To view or add a comment, sign in A strong perspective from Life Science Leader on how life sciences companies are moving beyond the prescription to create more connected, consumer-centered treatment experiences
In a prospective study of T2DM patients, six months of liraglutide therapy improved diastolic function and reduced left ventricular mass index [44], while additional echocardiographic studies have reported improvements in global longitudinal strain and left ventricular mass with GLP-1 receptor agonists [45]
According to the agency, it doesnt review compounded drugs for safety, effectiveness or quality before they are marketed. That doesnt make them inherently dangerous, Davis says
Gallbladder problems: Watch for upper abdominal pain, fever, jaundice, or clay-colored stools, which could indicate gallbladder issues
Skipping the logo wall entirely is more honest than displaying logos with no working outbound links